Code
Listing of Previous and Concomitant Medications
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
Date of First Ongoing
Study Drug Medication Duration at Final
Treatment Center/Patient ID Age/Sex/Race Medication Name Administration Start Date Study Day (days) Previous? Contact? Dose Dose Unit Frequency Route
———————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————————
A: Drug X BRA-1/id-134 47/M/WHITE medname A_2/3 04NOV2020 21SEP2021 321 -148 No No 30 mg/breath Q4H INTRAMUSCULAR
04NOV2020 02DEC2021 393 -42 No No 41 umol/L TWICE UNKNOWN
medname B_1/4 04NOV2020 15APR2021 162 -172 No No 25 ug/kg/day Q4H INTRAVENOUS
04NOV2020 15APR2021 162 -172 No No 25 ug/kg/day Q4H INTRAVENOUS
04NOV2020 15APR2021 162 -172 No No 25 ug/kg/day Q4H INTRAVENOUS
medname C_1/2 04NOV2020 19MAY2021 196 -165 No No 22 ug/mL TID INHALED
04NOV2020 19MAY2021 196 -165 No No 22 ug/mL TID INHALED
BRA-1/id-42 36/M/BLACK OR AFRICAN AMERICAN medname A_2/3 01JAN2020 09JUN2020 160 -258 No Yes 48 DROP QD INTRAVENOUS
01JAN2020 04APR2021 459 -194 No Yes 57 ug/kg/day Q4W NASAL
01JAN2020 15APR2021 470 -130 No Yes 83 ug/kg/day Q4H UNKNOWN
01JAN2020 20APR2021 475 -112 No Yes 17 ug/kg/day Q4H SUBCUTANEOUS
medname A_3/3 01JAN2020 03OCT2021 641 -14 No Yes 68 % 4 TIMES PER MONTH UNKNOWN
01JAN2020 03OCT2021 641 -14 No Yes 68 % 4 TIMES PER MONTH UNKNOWN
medname B_1/4 01JAN2020 19OCT2020 292 -49 No Yes 5 ug/mL TWICE UNKNOWN
01JAN2020 19OCT2020 292 -49 No Yes 5 ug/mL TWICE UNKNOWN
01JAN2020 19OCT2020 292 -49 No Yes 5 ug/mL TWICE UNKNOWN
medname B_2/4 01JAN2020 11MAY2021 496 -161 No Yes 83 ug/mL TWICE RECTAL
01JAN2020 11MAY2021 496 -161 No Yes 83 ug/mL TWICE RECTAL
01JAN2020 11MAY2021 496 -161 No Yes 83 ug/mL TWICE RECTAL
medname B_3/4 01JAN2020 09FEB2020 39 -505 No Yes 85 ug QD SUBCUTANEOUS